3rd Quarter - Report

MARC ASSOCIATES, INC. for AMERICAN SOCIETY OF HEMATOLOGY

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Physician Fee Schedule Medicare Reimbursement for Drugs and Biologicals Medicare Coverage Policies Medicare Hospital Outpatient Payment System

LobbyistCovered position, as disclosed
BERNARD PATASHNIK —
ELLEN RIKER —

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Pharmacy PHA

Oncology drug issues.

LobbyistCovered position, as disclosed
ELLEN RIKER —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

FY 2009 Labor, HHS, Education Appropriations Bills Hematology Research

LobbyistCovered position, as disclosed
ELLEN RIKER —

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.